Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDS. (linkinghub.elsevier.com)

Authors: Marx L … Ivanschitz L Journal: Cell Reports Medicine Published: 2026-05-19 DOI: https://doi.org/10.1016/j.xcrm.2026.102749